This inventor holds 4 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Constellation Pharmaceuticals, Inc.. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: The Innovative Contributions of Francois Brucelle
Introduction
Francois Brucelle is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he has focused on developing novel compounds that address various medical conditions.
Latest Patents
Among his latest patents are LSD1 inhibitors and their medical uses. These patents provide novel compounds that are useful for treating a variety of diseases associated with LSD1. Additionally, he has developed pharmaceutical compositions that include these compounds and methods for their use in treating related conditions. Another significant patent involves P300/CBP HAT inhibitors, which are compounds that can be used to treat conditions associated with histone acetyltransferase (HAT).
Career Highlights
Francois Brucelle is currently associated with Constellation Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work has the potential to impact the treatment of various diseases significantly.
Collaborations
He has collaborated with notable colleagues such as Victor S Gehling and Avinash Khanna, contributing to a dynamic research environment that fosters innovation.
Conclusion
Francois Brucelle's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and ongoing research are paving the way for new treatments that could benefit many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile